Yago H, Kohgo Y, Kato J, Watanabe N, Sakamaki S, Niitsu Y
Fourth Department of Internal Medicine, Sapporo Medical University School of Medicine, Japan.
Hepatology. 1995 Feb;21(2):383-8.
We describe the first evidence that soluble asialoglycoprotein receptors (AGPR) are present in human serum and that they are quantifiable by an enzyme-linked immunosorbent assay (ELISA). An affinity chromatography gel immobilized with monoclonal antibodies (McAbs) against human liver AGPR was mixed with normal sera, and the bound fraction was analyzed both by sodium dodecyl sulfate polyacrylamide gel electrophoresis and by Western blot analysis. Immunoreactive bands corresponding to 35 to 40 kd were obtained, which were lower than those of liver AGPR (41 kd and 46 kd). Soluble AGPR in human serum was able to bind to D-galactose-immobilized beads, indicating that the soluble AGPR remained ligand-binding activity. In order to quantify soluble AGPR, we established an ELISA using a monoclonal antibody (30220 McAb)-immobilized microplate and horseradish peroxidase-labeled F(ab')2 of another monoclonal antibody (30201 McAb). Reproducibility of intra- and interassay of the ELISA were 4% to 14% and 7% to 14%, respectively. Analytical recoveries ranged from 93% to 99%. The detection limit was estimated to be 0.1 micrograms/L. By nonparametolic analysis, a median and a 90% tile of serum AGPR level obtained from 283 normal volunteers were 0.4 micrograms/L and 2.4 micrograms/L, respectively.
我们首次证实,可溶性去唾液酸糖蛋白受体(AGPR)存在于人体血清中,并且可以通过酶联免疫吸附测定(ELISA)进行定量分析。将固定有抗人肝脏AGPR单克隆抗体(McAbs)的亲和层析凝胶与正常血清混合,通过十二烷基硫酸钠聚丙烯酰胺凝胶电泳和蛋白质印迹分析对结合部分进行分析。得到了对应于35至40kd的免疫反应条带,其分子量低于肝脏AGPR(41kd和46kd)。人血清中的可溶性AGPR能够与固定有D-半乳糖的珠子结合,表明可溶性AGPR保留了配体结合活性。为了定量可溶性AGPR,我们使用固定有单克隆抗体(30220 McAb)的微孔板和另一种单克隆抗体(30201 McAb)的辣根过氧化物酶标记的F(ab')2建立了ELISA。ELISA法批内和批间的重现性分别为4%至14%和7%至14%。分析回收率在93%至99%之间。检测限估计为0.1μg/L。通过非参数分析,从283名正常志愿者获得的血清AGPR水平的中位数和第90百分位数分别为0.4μg/L和2.4μg/L。